Loading...
Loading...
Loading...
Loading...
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
Loading insider data…
| Date | Headline | Sentiment |
|---|---|---|
| SAB Biotherapeutics Q2 2026, Cash Balance Of $208.0M, Providing Runway Through 2028 |
|